BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 20363302)

  • 1. Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect.
    Miyako Y; Khalef N; Matsuzaki K; Pinal R
    Int J Pharm; 2010 Jun; 393(1-2):48-54. PubMed ID: 20363302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization by cosolvents. Establishing useful constants for the log-linear model.
    Millard J; Alvarez-Núñez F; Yalkowsky S
    Int J Pharm; 2002 Oct; 245(1-2):153-66. PubMed ID: 12270252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility of hydrophobic compounds in water-cosolvent mixtures: relation of solubility with water-cosolvent interactions.
    Miyako Y; Zhao Y; Takeshima K; Kataoka T; Handa T; Pinal R
    J Pharm Sci; 2010 Jan; 99(1):293-302. PubMed ID: 19548311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilinear model for the prediction of drug solubility in ethanol/water mixtures.
    Machatha SG; Yalkowsky SH
    J Pharm Sci; 2005 Dec; 94(12):2731-4. PubMed ID: 16258999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility improvement of drugs using N-methyl pyrrolidone.
    Sanghvi R; Narazaki R; Machatha SG; Yalkowsky SH
    AAPS PharmSciTech; 2008; 9(2):366-76. PubMed ID: 18431671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
    Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
    Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cosolvency and deviations from log-linear solubilization.
    Rubino JT; Yalkowsky SH
    Pharm Res; 1987 Jun; 4(3):231-6. PubMed ID: 3509286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubility screening on a series of structurally related compounds: cosolvent-induced changes on the activity coefficient of hydrophobic solutes.
    Miyako Y; Tai H; Ikeda K; Kume R; Pinal R
    Drug Dev Ind Pharm; 2008 May; 34(5):499-505. PubMed ID: 18473232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization of poorly soluble compounds using 2-pyrrolidone.
    Jain P; Yalkowsky SH
    Int J Pharm; 2007 Sep; 342(1-2):1-5. PubMed ID: 17570624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent.
    Kawakami K; Miyoshi K; Ida Y
    J Pharm Sci; 2004 Jun; 93(6):1471-9. PubMed ID: 15124205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization by cosolvents I: organic solutes in propylene glycol-water mixtures.
    Yalkowsky SH; Rubino JT
    J Pharm Sci; 1985 Apr; 74(4):416-21. PubMed ID: 3999002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deviations of drug solubility in water-cosolvent mixtures from the Jouyban-Acree model--effect of solute structure.
    Jouyban A; Fakhree MA; Ghafourian T; Saei AA; Acree WE
    Pharmazie; 2008 Feb; 63(2):113-21. PubMed ID: 18380397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cosolvents on the binding interaction between poly(ethylene oxide) and sodium dodecyl sulfate.
    Dai S; Tam KC
    J Phys Chem B; 2006 Oct; 110(42):20794-800. PubMed ID: 17048889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of Fluasterone in cosolvent/cyclodextrin combinations.
    He Y; Li P; Yalkowsky SH
    Int J Pharm; 2003 Oct; 264(1-2):25-34. PubMed ID: 12972333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility of organic solutes in ethanol/water mixtures.
    Li A; Yalkowsky SH
    J Pharm Sci; 1994 Dec; 83(12):1735-40. PubMed ID: 7891303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations.
    Miller JM; Beig A; Carr RA; Webster GK; Dahan A
    Mol Pharm; 2012 Mar; 9(3):581-90. PubMed ID: 22280478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new definition of solubilization power of a cosolvent.
    Jouyban A; Fakhree MA
    Pharmazie; 2008 Apr; 63(4):317-9. PubMed ID: 18468394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility prediction of drugs in mixed solvents using partial solubility parameters.
    Jouyban A; Shayanfar A; Panahi-Azar V; Soleymani J; Yousefi BH; Acree WE; York P
    J Pharm Sci; 2011 Oct; 100(10):4368-82. PubMed ID: 21630276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubility parameter of drugs for predicting the solubility profile type within a wide polarity range in solvent mixtures.
    Peña MA; Reíllo A; Escalera B; Bustamante P
    Int J Pharm; 2006 Sep; 321(1-2):155-61. PubMed ID: 16828993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.